Click a link below to view the mailing archive as if it had been sent to you.
| 2018-02-28 12:15 | | On Rare Disease Day, recognizing the life and work of biotech giant Henri A. Termeer and more... |
| 2018-02-28 00:15 | | Diabetic Retinopathy Could Soon be Diagnosed by AI System and more... |
| 2018-02-27 12:15 | | Regulatory Intelligence: 2017 FDA Review and Trends to Watch and more... |
| 2018-02-27 00:15 | | FDA to Launch New Pilot Program for Orphan Designation Requests and more... |
| 2018-02-26 12:15 | | Grey Hair In the C-Suite: Experience, Age, And IPOs In Biotech and more... |
| 2018-02-25 12:15 | | Novartis rolls out heart-helping data for Ultibro COPD edge and more... |
| 2018-02-25 00:15 | | Bristol losing its I/O talent to the likes of Pfizer, report finds and more... |
| 2018-02-24 12:15 | | 3 Big Drugmakers Boosting Huge R&D Budgets and more... |
| 2018-02-23 12:15 | | Are Amazon’s Private Label OTC Medications a Stepping Stone to Prescription Drug Sales? and more... |
| 2018-02-23 00:15 | | Top drugmakers are counting on two hot drug fields—migraine and NASH—but payers are ready to rumble and more... |
| 2018-02-22 12:15 | | If Pfizer is itching to make a major deal, Bristol-Myers Squibb is probably on its radar screen and more... |
| 2018-02-22 00:15 | | Merck to buy virus-based cancer drug firm Viralytics for $394 million and more... |
| 2018-02-21 12:15 | | 4 Positive Changes Happening in Pharmaceutical Sales in 2018 and more... |
| 2018-02-21 00:15 | | FDA removed 10% of medtech establishments from its registration database: Here’s why and more... |
| 2018-02-20 12:15 | | AstraZeneca hauls kidney disease drug into the clinic after handing Ionis $30M in cash, $300M in milestones and more... |
| 2018-02-20 00:15 | | AbbVie Presents New Data on Upadacitinib for Crohn's Disease |
| 2018-02-19 12:15 | | Eli Lilly shutters a failed PhII for rheumatoid arthritis, clouding $690M Hanmi pact and more... |
| 2018-02-19 00:15 | | The Deeply Human Core of Roche's $2.1B Tech Acquisition - And Why They Did It |
| 2018-02-18 12:15 | | The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs and more... |
| 2018-02-17 12:15 | | Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles and more... |
| 2018-02-17 00:15 | | AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst and more... |
| 2018-02-16 12:15 | | How Pharma Can Minimize Political Risk From Its Repatriation Windfall and more... |
| 2018-02-16 00:15 | | Johnson & Johnson’s stay-out-of-jail marketing for schizophrenia blockbuster Invega Sustenna raises eyebrows and more... |
| 2018-02-15 12:15 | | 3 Great Acquisition Targets for Gilead Sciences -- and 1 Iffy Candidate and more... |
| 2018-02-15 00:15 | | Is FDA Getting More Cozy with AI? and more... |
| 2018-02-14 12:15 | | Bristol-Myers To Pay Largest Fee In Biotech History For Nektar Cancer Drug and more... |
| 2018-02-14 00:15 | | Merck just dashed the last remaining hopes for its industry-leading BACE drug for Alzheimer’s and more... |
| 2018-02-13 12:15 | | $100B in NIH-funded research played an important role in all 210 new drugs approved over 7 years — study and more... |
| 2018-02-13 00:15 | | What’s the trouble with pain? Analysis shows scarce investments, high failure rate for new drugs and more... |
| 2018-02-12 12:15 | | Top 10 most productive workforces in biopharma and more... |
| 2018-02-12 00:15 | | Amgen still far from performing an important acquisition and more... |
| 2018-02-10 12:15 | | Regeneron’s coming late to a group of drugs that’s already worth billions — here’s why the company thinks it can still compete and more... |
| 2018-02-09 12:15 | | Pharma to pay more under 2-year budget deal and more... |
| 2018-02-09 00:15 | | CVS Health CEO On Amazon-Berkshire Threat: We've Got This and more... |
| 2018-02-08 12:15 | | No more Mr Nice Guy: GlaxoSmithKline is coming out of its corner swinging and more... |
| 2018-02-08 00:15 | | Sanofi Leads the Hemophilia Space on Bioverativ Acquisition and more... |
| 2018-02-07 12:15 | | Sanofi sounds taps on a half dozen drug programs in latest pipeline cleanup and more... |
| 2018-02-07 00:15 | | With private equity bidders lined up, Sanofi's EU generics could go for up to $2.4B: Reuters and more... |
| 2018-02-06 12:15 | | Johnson & Johnson falls on report that lawsuits could expose potentially damaging documents and more... |
| 2018-02-06 00:15 | | Allergan's Pipeline Matters More Than Its Earnings Do: RBC and more... |
| 2018-02-05 12:15 | | Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment and more... |
| 2018-02-04 12:15 | | Glaxo, Reckitt Submit Only Bids for Pfizer's Consumer Unit and more... |
| 2018-02-03 12:15 | | Here's What Pfizer's Saying About Its Future and more... |
| 2018-02-03 00:15 | | Spread of diabetes in the world: state of the art and more... |
| 2018-02-02 12:15 | | Merck quarterly profit beats on Keytruda demand and more... |
| 2018-02-02 00:15 | | Roche announces slower growth in 2018 and investors lose interest in it and more... |
| 2018-02-01 12:15 | | As states target high drug prices, pharma targets state lawmakers and more... |
| 2018-02-01 00:15 | | PhRMA points finger at insurers on new drug cost website for consumers and more... |
